Stockreport

Positive Data On BioCardia's Investigational CardiAMP Cell Therapy For Heart Failure Presented At Transcatheter Cardiovascular Therapeutics (TCT) Conference

BioCardia, Inc.  (BCDA) 
PDF SAN DIEGO and SAN CARLOS, Calif., Sept. 24, 2018 /PRNewswire/ -- BioCardia®, Inc. (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular [Read more]